Loading…
Annexon, Inc. is projected to rise to $6.28 by 2027, a +8% move from its current price of $5.80. ANNX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $5.59 | $5.80 | $6.02 | +0.07% |
| Jul 14 | $5.51 | $5.81 | $6.12 | +0.14% |
| Jul 15 | $5.45 | $5.81 | $6.20 | +0.21% |
| Jul 16 | $5.40 | $5.82 | $6.26 | +0.28% |
| Jul 17 | $5.36 | $5.82 | $6.32 | +0.34% |
| Jul 18 | $5.32 | $5.82 | $6.37 | +0.41% |
| Jul 19 | $5.29 | $5.83 | $6.43 | +0.48% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $5.29 | $5.83 | $6.43 | +0.48% |
| Week 2 | $5.10 | $5.86 | $6.72 | +0.97% |
| Week 3 | $4.97 | $5.88 | $6.97 | +1.45% |
| Week 4 | $4.86 | $5.91 | $7.19 | +1.94% |
| Week 5 | $4.78 | $5.94 | $7.39 | +2.44% |
| Week 6 | $4.70 | $5.97 | $7.58 | +2.93% |
| Week 7 | $4.63 | $6.00 | $7.77 | +3.43% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Annexon, Inc. is a healthcare company described as a clinical-stage biopharmaceutical company that discovers and develops medicines for treating inflammatory-related diseases. It provides Tanruprubart, an investigational full-length monoclonal antibody, which is in Phase 3 clinical trial for the treatment of patients with guillain-barré syndrome; completed Phase II clinical trial for treating Huntington's disease; and in Phase 2a clinical trial for the treatment of amyotrophic lateral sclerosis.
It is also developing ANX007, an antigen-binding fragment (Fab) that is in Phase 3 program for the treatment of patients with geographic atrophy; and ANX1502, a novel oral small molecule inhibitor, which is in Phase 1 clinical trials for autoimmune indications. In addition, it develops ANX009, a C1q-blocking Fab that is in Phase I clinical trial for treating patients with lupus nephritis. The company was incorporated in 2011 and is headquartered in Brisbane, California.
Annexon, Inc. (ANNX) is currently trading at $5.96 per share with a market cap of $976.5M, and it ranks 2582. The current price sits in the context of a bullish technical outlook for the period ahead.
A major floor 36.7% below — a decisive break under it would weaken the trend.
The nearest floor, 22.1% below — buyers have tended to step in here.
The nearest ceiling, 10.9% above — a clean break opens room to run.
A major ceiling 29.2% above — clearing it would confirm fresh momentum.
Key ANNX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ANNX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $6.02 | Sell | $5.89 | Sell |
| MA 10 | $5.79 | Buy | $5.76 | Buy |
| MA 20 | $5.35 | Buy | $5.56 | Buy |
| MA 50 | $5.39 | Buy | $5.46 | Buy |
| MA 100 | $5.50 | Buy | $5.37 | Buy |
| MA 200 | $4.95 | Buy | $4.97 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 55.75 | Neutral |
| Stoch RSI (14) | 36.73 | Neutral |
| CCI (20) | 68.82 | Neutral |
| Williams %R (14) | -45.32 | Info |
| MACD (12,26,9) | 0.08 | Buy |
| ROC (12) | 9.85 | Buy |
| Bollinger %B (20,2) | 0.72 | Neutral |
| Stochastic %K (14) | 54.68 | Neutral |
| TRIX (15) | 0.28 | Buy |
| Awesome (5,34) | 0.68 | Buy |
| Ultimate (7,14,28) | 56.26 | Neutral |
| Momentum (10) | 0.65 | Buy |
| Aroon Osc (25) | 52.00 | Buy |
| Hull MA (9) | 6.10 | Sell |
| ADX (14) | 16.88 | Neutral |
| ATR (14) | 0.20 | Info |
The 30-day technical picture is bullish, with RSI(14) at 60. The moving averages show SMA50 at $5.39 and SMA200 at $4.92, highlighting a positive short-term bias.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.52 | $5.80 | $7.85 | 0% | Neutral | |
| $4.84 | $6.28 | $8.72 | +8% | Neutral | |
| $5.06 | $6.83 | $9.95 | +18% | Neutral | |
| $5.65 | $7.88 | $11.90 | +36% | Bullish | |
| $6.41 | $9.20 | $14.33 | +59% | Bullish | |
| $7.84 | $11.58 | $18.52 | +100% | Bullish | |
| $8.57 | $12.96 | $21.24 | +124% | Bullish | |
| $8.67 | $13.44 | $22.49 | +132% | Bullish | |
| $8.52 | $13.52 | $23.07 | +133% | Bullish | |
| $8.33 | $13.50 | $23.46 | +133% | Bullish | |
| $13.21 | $23.71 | $44.45 | +309% | Bullish | |
| $20.32 | $43.85 | $91.64 | +656% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $4.52 | $5.80 | $6.94 | +0.00% |
| August 2026 | $4.95 | $5.90 | $7.25 | +1.66% |
| September 2026 | $5.13 | $6.18 | $7.71 | +4.73% |
| October 2026 | $5.06 | $6.13 | $7.75 | -0.69% |
| November 2026 | $4.87 | $5.95 | $7.60 | -2.96% |
| December 2026 | $4.95 | $6.09 | $7.85 | +2.25% |
Click any year to see its month-by-month ANNX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, ANNX could reach as high as $7.85, with a base case around $5.80 and support toward $4.52 — roughly 0% from $5.80. Price action looks broadly range-bound.
Expect ANNX to range from $4.84 to $8.72 through 2027. The $6.28 average target implies a +8% move from current prices. That is up +8% on the projected 2026 average. A consolidation phase looks the most probable path here.
The ANNX price prediction for 2028 points to an average of $6.83 (low $5.06, high $9.95) — a potential gain of +18% on today's $5.80. Price action looks broadly range-bound.
In 2029, ANNX is projected to trade between $5.65 and $11.90, averaging $7.88 — a potential gain of +36% from today's $5.80. That is up +15% on the projected 2028 average. Buyers look set to stay in control over this stretch.
Annexon, Inc.'s 2030 outlook centres on $9.20, within a $6.41 to $14.33 range. That is up +17% on the projected 2029 average. That marks a +59% change versus current levels. Momentum favours further upside here.
By 2031, ANNX could reach as high as $18.52, with a base case around $11.58 and support toward $7.84 — roughly +100% from $5.80. Buyers look set to stay in control over this stretch.
Expect ANNX to range from $8.57 to $21.24 through 2032. The $12.96 average target implies a +124% move from current prices. That is up +12% on the projected 2031 average. Momentum favours further upside here.
The ANNX price prediction for 2033 points to an average of $13.44 (low $8.67, high $22.49) — a potential gain of +132% on today's $5.80. Buyers look set to stay in control over this stretch.
In 2034, ANNX is projected to trade between $8.52 and $23.07, averaging $13.52 — a potential gain of +133% from today's $5.80. That is up +1% on the projected 2033 average. Momentum favours further upside here.
Annexon, Inc.'s 2035 outlook centres on $13.50, within a $8.33 to $23.46 range. That is 0% versus the projected 2034 average. That marks a +133% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, ANNX could reach as high as $44.45, with a base case around $23.71 and support toward $13.21 — roughly +309% from $5.80. Momentum favours further upside here.
Expect ANNX to range from $20.32 to $91.64 through 2050. The $43.85 average target implies a +656% move from current prices. That is up +85% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in ANNX today (≈ 172.413793 ANNX) could be worth
$7,560.72
+$6,560.72 (+656%) by 2050 · US Dollar
Based on the average projected ANNX price of $43.85 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ANNXwould be worth at today's price.
$1,000 invested in ANNX on Jul 10, 2025 (≈ 357.142863 ANNX) would be worth
$2,071.43
+$1,071.43 (+107.1%) today · 2.07× · US Dollar
Based on a ANNX entry price of $2.8 vs. today's $5.8.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $5.46 | $1,062.27 | +6.2% |
| 1 month ago | $4.72 | $1,228.81 | +22.9% |
| 3 months ago | $5.85 | $991.45 | -0.9% |
| 6 months ago | $5.56 | $1,043.17 | +4.3% |
| 1 year ago | $2.8 | $2,071.43 | +107.1% |
| All time (5.0y) ago | $22.7 | $255.51 | -74.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ANNX forecast.
Our base-case forecast reaches $12.00 around 2032.
Implied market cap at $12.00: $1.97B
The multi-year forecast shows a rising path of average prices and substantial upside. In 2026 the average price is $5.96 with a 0% ROI and neutral sentiment, followed by 2027 at $6.50 (ROI 9.1%, neutral), 2028 at $7.12 (ROI 19.4%, neutral), and 2029 at $8.38 (ROI 40.6%, bullish). By 2030 the average is $9.86 with a bullish sentiment and an estimated ROI of 65.4%.
The trajectory continues with 2031 at $12.51 (ROI 110%), 2032 at $14.13 (ROI 137.2%), 2033 at $14.51 (ROI 143.5%), 2034 at $14.64 (ROI 145.6%), and 2035 at $14.75 (ROI 147.4%). The longer-horizon outlook strengthens to 2040 with an average of $26.35 (ROI 342.2%, bullish) and to 2050 with an average of $49.81 (ROI 735.7%, bullish). These figures are estimates and not guarantees.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $9.86 with a min of $6.77 and a max of $15.57, and an estimated ROI of 65.4% with a bullish sentiment.
Forecasts show a rising price path with bullish sentiment from 2029 onward and an average price climbing to $9.86 by 2030, $26.35 by 2040, and $49.81 by 2050, with ROIs of up to 735.7% by 2050. These are estimates, not guarantees.
Yes. The 2040 max is $50.44 and the 2050 max is $106.59, with the 2050 average at $49.81 and a bullish outlook.
The current price is $5.96 and the market cap is $976.5M.
For 2040 the average price is $26.35 with a max of $50.44 and ROI of 342.2%; for 2050 the average price is $49.81 with a max of $106.59 and ROI of 735.7%, both with a bullish sentiment.
Annexon, Inc. Community Discussion
0Share your Annexon, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.